Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
DYN.OQ - Dyne Therapeutics Inc
Dyne Therapeutics Inc at JPMorgan Healthcare Conference
Jan 15, 2026 / 01:15AM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome everyone to the forty-fourth annual JPMorgan Healthcare Conference. My name is Tessa Romero and I'm one of the senior biotech analysts here at JPMorgan. Our next presenting company is Dyn Therapeutics, and presenting on behalf of the company, we have President and CEO John Cox. John, over to you.
--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Tess. We'll be making some forward-looking comments. And move these slides forward.
I must say I think there are very few biotech companies that can say they have two transformative late stage assets,
Trustpilot
